TY - JOUR AU - Kim, H. S. AU - Park, K. AU - Jun, H. J. AU - Yi, S. Y. AU - Lee, J. AU - Ahn, J. S. AU - Park, Y. H. AU - Kim, S. AU - Lee, S. AU - Ahn, M. J. PY - 2009 DA - 2009// TI - Comparison of survival in advanced non-small cell lung cancer patients in the pre- and post-gefitinib eras JO - Oncology VL - 76 UR - https://doi.org/10.1159/000205386 DO - 10.1159/000205386 ID - Kim2009 ER - TY - CHAP AU - Coate, L. E. AU - Leighl, N. B. PY - 2011 DA - 2011// TI - How Affordable are Targeted Therapies in Non-Small Cell Lung Cancer? BT - Curr Treat Options Oncol ID - Coate2011 ER - TY - JOUR AU - Scagliotti, G. AU - Hanna, N. AU - Fossella, F. AU - Sugarman, K. AU - Blatter, J. AU - Peterson, P. AU - Simms, L. AU - Shepherd, F. A. PY - 2009 DA - 2009// TI - The differential efficacy of pemetrexed according to NSCLC histology: a review of two Phase III studies JO - Oncologist VL - 14 UR - https://doi.org/10.1634/theoncologist.2008-0232 DO - 10.1634/theoncologist.2008-0232 ID - Scagliotti2009 ER - TY - JOUR AU - Lorand, L. AU - Graham, R. M. PY - 2003 DA - 2003// TI - Transglutaminases: crosslinking enzymes with pleiotropic functions JO - Nature Reviews Molecular Cell Biology VL - 4 UR - https://doi.org/10.1038/nrm1014 DO - 10.1038/nrm1014 ID - Lorand2003 ER - TY - JOUR AU - Han, J. A. AU - Park, S. C. PY - 1999 DA - 1999// TI - Reduction of transglutaminase 2 expression is associated with an induction of drug sensitivity in the PC-14 human lung cancer cell line JO - J Cancer Res Clin Oncol VL - 125 UR - https://doi.org/10.1007/s004320050247 DO - 10.1007/s004320050247 ID - Han1999 ER - TY - JOUR AU - Cao, L. AU - Petrusca, D. N. AU - Satpathy, M. AU - Nakshatri, H. AU - Petrache, I. AU - Matei, D. PY - 2008 DA - 2008// TI - Tissue transglutaminase protects epithelial ovarian cancer cells from cisplatin-induced apoptosis by promoting cell survival signaling JO - Carcinogenesis VL - 29 UR - https://doi.org/10.1093/carcin/bgn158 DO - 10.1093/carcin/bgn158 ID - Cao2008 ER - TY - JOUR AU - Mehta, K. PY - 1994 DA - 1994// TI - High levels of transglutaminase expression in doxorubicin-resistant human breast carcinoma cells JO - International journal of cancer VL - 58 UR - https://doi.org/10.1002/ijc.2910580316 DO - 10.1002/ijc.2910580316 ID - Mehta1994 ER - TY - JOUR AU - Mehta, K. AU - Fok, J. AU - Miller, F. R. AU - Koul, D. AU - Sahin, A. PY - 2004 DA - 2004// TI - Prognostic significance of tissue transglutaminase in drug resistant and metastatic breast cancer JO - Clinical cancer research VL - 10 UR - https://doi.org/10.1158/1078-0432.CCR-04-1107 DO - 10.1158/1078-0432.CCR-04-1107 ID - Mehta2004 ER - TY - JOUR AU - Park, K. S. AU - Kim, H. K. AU - Lee, J. H. AU - Choi, Y. B. AU - Park, S. Y. AU - Yang, S. H. AU - Kim, S. Y. AU - Hong, K. M. PY - 2010 DA - 2010// TI - Transglutaminase 2 as a cisplatin resistance marker in non-small cell lung cancer JO - J Cancer Res Clin Oncol VL - 136 UR - https://doi.org/10.1007/s00432-009-0681-6 DO - 10.1007/s00432-009-0681-6 ID - Park2010 ER - TY - JOUR AU - Antonyak, M. A. AU - Li, B. AU - Regan, A. D. AU - Feng, Q. AU - Dusaban, S. S. AU - Cerione, R. A. PY - 2009 DA - 2009// TI - Tissue transglutaminase is an essential participant in the epidermal growth factor-stimulated signaling pathway leading to cancer cell migration and invasion JO - J Biol Chem VL - 284 UR - https://doi.org/10.1074/jbc.M109.013037 DO - 10.1074/jbc.M109.013037 ID - Antonyak2009 ER - TY - JOUR AU - Hwang, J. Y. AU - Mangala, L. S. AU - Fok, J. Y. AU - Lin, Y. G. AU - Merritt, W. M. AU - Spannuth, W. A. AU - Nick, A. M. AU - Fiterman, D. J. AU - Vivas-Mejia, P. E. AU - Deavers, M. T. PY - 2008 DA - 2008// TI - Clinical and biological significance of tissue transglutaminase in ovarian carcinoma JO - Cancer Res VL - 68 UR - https://doi.org/10.1158/0008-5472.CAN-07-6130 DO - 10.1158/0008-5472.CAN-07-6130 ID - Hwang2008 ER - TY - JOUR AU - Mangala, L. S. AU - Fok, J. Y. AU - Zorrilla-Calancha, I. R. AU - Verma, A. AU - Mehta, K. PY - 2007 DA - 2007// TI - Tissue transglutaminase expression promotes cell attachment, invasion and survival in breast cancer cells JO - Oncogene VL - 26 UR - https://doi.org/10.1038/sj.onc.1210035 DO - 10.1038/sj.onc.1210035 ID - Mangala2007 ER - TY - JOUR AU - Satpathy, M. AU - Cao, L. AU - Pincheira, R. AU - Emerson, R. AU - Bigsby, R. AU - Nakshatri, H. AU - Matei, D. PY - 2007 DA - 2007// TI - Enhanced peritoneal ovarian tumor dissemination by tissue transglutaminase JO - Cancer Res VL - 67 UR - https://doi.org/10.1158/0008-5472.CAN-07-0307 DO - 10.1158/0008-5472.CAN-07-0307 ID - Satpathy2007 ER - TY - STD TI - Chen SH, Lin CY, Lee LT, Chang GD, Lee PP, Hung CC, Kao WT, Tsai PH, Schally AV, Hwang JJ, Lee MT: Up-regulation of fibronectin and tissue transglutaminase promotes cell invasion involving increased association with integrin and MMP expression in A431 cells. Anticancer Res. 30: 4177-4186. ID - ref14 ER - TY - JOUR AU - Loo, P. S. AU - Thomas, S. C. AU - Nicolson, M. C. AU - Fyfe, M. N. AU - Kerr, K. M. PY - 2010 DA - 2010// TI - Subtyping of undifferentiated non-small cell carcinomas in bronchial biopsy specimens JO - J Thorac Oncol VL - 5 UR - https://doi.org/10.1097/JTO.0b013e3181d40fac DO - 10.1097/JTO.0b013e3181d40fac ID - Loo2010 ER - TY - JOUR AU - Jeong, J. M. AU - Murthy, S. N. AU - Radek, J. T. AU - Lorand, L. PY - 1995 DA - 1995// TI - The fibronectin-binding domain of transglutaminase JO - J Biol Chem VL - 270 UR - https://doi.org/10.1074/jbc.270.10.5654 DO - 10.1074/jbc.270.10.5654 ID - Jeong1995 ER - TY - JOUR AU - Hang, J. AU - Zemskov, E. A. AU - Lorand, L. AU - Belkin, A. M. PY - 2005 DA - 2005// TI - Identification of a novel recognition sequence for fibronectin within the NH2-terminal beta-sandwich domain of tissue transglutaminase JO - J Biol Chem VL - 280 UR - https://doi.org/10.1074/jbc.M503323200 DO - 10.1074/jbc.M503323200 ID - Hang2005 ER - TY - JOUR AU - Janiak, A. AU - Zemskov, E. A. AU - Belkin, A. M. PY - 2006 DA - 2006// TI - Cell surface transglutaminase promotes RhoA activation via integrin clustering and suppression of the Src-p190RhoGAP signaling pathway JO - Mol Biol Cell VL - 17 UR - https://doi.org/10.1091/mbc.E05-06-0549 DO - 10.1091/mbc.E05-06-0549 ID - Janiak2006 ER - TY - JOUR AU - Lipscomb, E. A. AU - Mercurio, A. M. PY - 2005 DA - 2005// TI - Mobilization and activation of a signaling competent alpha6beta4integrin underlies its contribution to carcinoma progression JO - Cancer Metastasis Rev VL - 24 UR - https://doi.org/10.1007/s10555-005-5133-4 DO - 10.1007/s10555-005-5133-4 ID - Lipscomb2005 ER - TY - JOUR AU - Kumar, A. AU - Xu, J. AU - Brady, S. AU - Gao, H. AU - Yu, D. AU - Reuben, J. AU - Mehta, K. PY - 2010 DA - 2010// TI - Tissue transglutaminase promotes drug resistance and invasion by inducing mesenchymal transition in mammary epithelial cells JO - PLoS One VL - 5 UR - https://doi.org/10.1371/journal.pone.0013390 DO - 10.1371/journal.pone.0013390 ID - Kumar2010 ER - TY - JOUR AU - Kim, D. AU - Park, S. AU - Nam, B. AU - Kim, I. AU - Kim, S. PY - 2006 DA - 2006// TI - Reversal of drug resistance in breast cancer cells by transglutaminase 2 inhibition and nuclear factor-kappaB inactivation JO - Cancer research VL - 66 UR - https://doi.org/10.1158/0008-5472.CAN-06-1521 DO - 10.1158/0008-5472.CAN-06-1521 ID - Kim2006 ER - TY - JOUR AU - Mann, A. P. AU - Verma, A. AU - Sethi, G. AU - Manavathi, B. AU - Wang, H. AU - Fok, J. Y. AU - Kunnumakkara, A. B. AU - Kumar, R. AU - Aggarwal, B. AU - Mehta, K. PY - 2006 DA - 2006// TI - Overexpression of tissue transglutaminase leads to constitutive activation of nuclear factor-kappaB in cancer cells: delineation of a novel pathway JO - Cancer research VL - 66 UR - https://doi.org/10.1158/0008-5472.CAN-06-1457 DO - 10.1158/0008-5472.CAN-06-1457 ID - Mann2006 ER -